Neonatal Conjunctivitis Therapeutics Market Worldwide Industry Analysis, Future Demand and Forecast till 2029

Neonatal Conjunctivitis Therapeutics Market is anticipated to grow at a significant CAGR during the forecast period. Conjunctivitis is a kind of eye condition, which is commonly known as pink eye since the inflammation due to the infection makes the white part of the eye look red/pink. Neonatal conjunctivitis is also known as ophthalmia neonatorum. Neonatal conjunctivitis occurs in infants within the first 28 days of birth. In the first place, the disease gets acquired during the passage of the neonate through the infected birth canal. Some of the common microorganisms that cause the infection include Chlamydia trachomatis, Staphylococcus aureus, Staphylococcus epidermis, Escherichia coli, Neisseria gonorrhoea, other gram-negative bacteria and Herpes Simplex Virus.

Another factor contributing to the market growth includes the increasing awareness among the global population that surge the demand for treatment of neonatal conjunctivitis. As a result, several biopharmaceutical companies have planned to invest in R&D initiatives to novel drugs and therapies for the treatment of this disorder. For instance, in July 2020, Zhaoke Ophthalmology Pharmaceutical Ltd. and IACTA Pharmaceuticals signed an agreement to accelerate the development of drugs called IC 265 and IC 270. The former is developed to treat dry eye and the latter for ocular allergy.

Some key players operating in the market include Merck & Co. Inc., Akorn Inc, Pfizer Inc., Bayer AG, among others. These players are aiming at strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on.

To Request a Sample of our Report on Neonatal Conjunctivitis Therapeutics Market: https://www.omrglobal.com/request-sample/neonatal-conjunctivitis-therapeutics-market

Market Coverage

· The market number available for - 2020-2030

· Base year- 2022

· Forecast period- 2023-2030

· Segment Covered

· Regions Covered- Globally

· Competitive Landscape: Merck & Co. Inc., Akorn Inc, Pfizer Inc., Bayer AG, among others.

A full Report of Neonatal Conjunctivitis Therapeutics Market is Available at: https://www.omrglobal.com/industry-reports/neonatal-conjunctivitis-therapeutics-market

Neonatal Conjunctivitis Therapeutics Market by Segment

By Treatment Administration

• Oral

• Topical

• Intramuscular and Intravenous

By Distribution Channel

• Hospital Pharmaciess

• Retail Pharmacies

• Drug Stores

• E-Commerce

Neonatal Conjunctivitis Therapeutics Market by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.